const data = [
  {
    title: ' Assessment of protection from Beta HPV infections upon multimer vaccination in Epidermodysplasia verruciformis and wild type mouse models',
    // subtitle: '',
    // link: '',
    image: '/images/projects/hpv.jpeg',
    date: '2019',
    desc:
      'Growing evidence shows a potential link between infections with Beta HPV and development of cutaneous squamous '
      + 'cell carcinoma (CSCC). Annually, 4000-7000 patients die from CSCC in the USA. CSCC occur at especially high '
      + 'rates in un-exposed areas of organ transplant recipients (OTRs), HIV+ and epidermodysplasia verruciformis (EV) '
      + 'patients in association with Beta HPV. Current HPV vaccine technology is designed to target up to 9 HPV types from '
      + 'alpha genera, but not beta HPV. Vaccination with a fusion protein which incorporates L2 residues 11-88 of five '
      + 'Alpha HPV (L2 multimer a11-88x5). I showed that vaccination of wild type and EV model mice  protects against diverse Beta HPV.'
      + 'of various HPV types. ',
  },
  {
    title: 'Assessment of protection from Beta HPV infections upon bi-valent vaccination in mice and rabbits',
    // subtitle: '',
    // link: '',
    image: '/images/projects/chem.jpeg',
    date: '2020',
    desc: 'This project is a continuation of the development of vaccine technology that displays L2 '
        + 'aa 17-36 is displayed within an immunodominant surface loop of HPV16 L1 VLP. Previous '
        + 'work in the lab showed that vaccination with this chimeric vaccine, termed RGVax, '
        + 'induced L2 antibodies that neutralized and protected against all oncogenic αHPV '
        + 'types. In this project, we developed a second chimeric HPV18 L1 VLP displaying a '
        + 'similar L2 epitope bioinformatically designed to broadly target Beta HPVs. We study wild '
        + 'type and EV model TMC6-/- or TMC8-/- FVB mice to determine whether the combination '
        + 'of the two chimeric VLPs  is protective against the challenge with beta HPVs. We also '
        + 'vaccinated rabbits to determine  disease caused by cutaneous challenge with the high '
        + 'risk HPV quazivirions including several types not covered by Gardasil9. This bivalent '
        + 'RGVax immunogen has potential to protect against infections of both Beta genotypes causing '
        + 'CSCC including in EV patients, and α genotypes causing anogenital cancers.',
  },
  {
    title: 'Assessment of antibody-mediated protection against βHPV in mice passively transferred with human sera',
    // subtitle: '',
    // link: '',
    image: '/images/projects/antibodies.jpeg',
    date: '2020',
    desc:
        'In collaboration with a biotech company, I helped to evaluate the results of a clinical '
        + 'trial. A group of patients were vaccinated with a chimeric viral-like particle (VLP) vaccine. Sera from vaccinated '
        + 'patients were collected by the company and assessed by me for protection against various disease-relevant '
        + 'alpha and beta HPV types by passive vaccination in mice. ',
  },
];

export default data;
